Medtronic Earnings Review: Stuck In The Single Digits Again
Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.
drugdeliverybusiness23h
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Medtronic price target raised to $91 from $90 at Baird
Baird analyst David Rescott raised the firm’s price target on Medtronic (MDT) to $91 from $90 and keeps a Neutral rating on the shares. The ...
Medtronic expects pressure in surgical unit for fourth quarter, shares fall
Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...
Medtronic’s stock drops on inventory hiccup and revenue miss
Jeff Jonas, portfolio manager at Gabelli Funds, said he’s surprised at the drop in Medtronic’s stock on the heels of its ...
drugdeliverybusiness4d
Medtronic warns on air pressure issue with certain MiniMed insulin pumps in Europe
Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe related to multiple versions of its MiniMed insulin pump ...
Yahoo Finance6d
Medtronic plc (MDT)
After hours: 14 February at 8:00:00 pm GMT-5 ...
Healio8d
Endocrinology News
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at ...